SFL Pharma’s Aumseqa Receives Approval in Europe
12 Feb 2026 //
EMA
Glenmark Acquires Exclusive Multi-Regional Rights To Aumolertinib
17 Dec 2025 //
INDPHARMAPOST
UK MHRA Approves Aumolertinib to Treat Non-Small Cell Lung Cancer
05 Jun 2025 //
INDPHARMAPOST

Market Place
Sourcing Support